StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report released on Friday. The firm issued a hold rating on the biotechnology company’s stock.
Research analysts at StockNews.com started coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage ...